TalkMed Group Ltd. 2022 AR2
The report highlights TalkMed Group's financial recovery in 2022, with revenue increasing by 26.2% to S$76.6 million due to the reopening of borders and the return of medical tourism. The company expanded its sustainability disclosures by identifying 'Climate and Environment' as a material topic and conducting its first baseline greenhouse gas emissions assessment, reporting 9 tonnes of Scope 1 and 1,528 tonnes of Scope 2 emissions. TalkMed maintained a strong governance record with zero confirmed incidents of corruption, non-compliance, or data privacy breaches. Additionally, the Group continued its community engagement as the title sponsor for the Singapore Cancer Society-TalkMed Relay for Life 2023, which raised approximately S$1 million.
Company: TalkMed Group Ltd.
Sector: Healthcare & social services
Country: Singapore
Year: 2022
Type: AR2
Pages: 160
TalkMed Group Ltd.
The report highlights TalkMed Group's financial recovery in 2022, with revenue increasing by 26.2% to S$76.6 million due to the reopening of borders and the return of medical tourism. The company expanded its sustainability disclosures by identifying 'Climate and Environment' as a material topic and conducting its first baseline greenhouse gas emissions assessment, reporting 9 tonnes of Scope 1 and 1,528 tonnes of Scope 2 emissions. TalkMed maintained a strong governance record with zero confirmed incidents of corruption, non-compliance, or data privacy breaches. Additionally, the Group continued its community engagement as the title sponsor for the Singapore Cancer Society-TalkMed Relay for Life 2023, which raised approximately S$1 million.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women on Board
Employees